PositiveID Corporation Discusses Detection of Zika Virus on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PositiveID Corporation Discusses Detection of Zika Virus on its Firefly Dx Prototype System in New Interview with SmallCapVoice.com

AUSTIN, Texas, Aug. 10, 2016 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics. In the interview, which can be heard at http://smallcapvoice.com/blog/8-8-16-smallcap...ation-psid , Lyle L. Probst, President of PositiveID, discusses the Company’s successful detection of Zika virus on its Firefly Dx polymerase chain reaction (“PCR”) breadboard prototype pathogen detection system (“prototype system”).

PositiveID used assay partner GenArraytion, Inc.’s Aedes Aegypti MultiFLEX™ PCR test, which targets four genetic regions of the Zika virus, on PositiveID’s Firefly Dx prototype system. PositiveID is developing the Firefly Dx prototype system to be a handheld, fully automated, lab quality, real-time device able to detect bio-threats at the point of need. Currently, PCR tests are run on large lab equipment and take a minimum of four hours to deliver results. A design advantage of Firefly Dx is that it does not require additional equipment or separate steps for sample preparation and purification, unlike current lab-based equipment, thus reducing time to results as well as cost per test.

The Firefly Dx prototype system has also successfully detected a number of other pathogenic organisms including E.coli, Ebola, influenza, MRSA, MSSA, C. diff and others.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html .

About PositiveID Corporation PositiveID Corporation is a life sciences company focused on detection and diagnostics, with an extensive patent portfolio. PositiveID specializes in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com , or connect with PositiveID on Twitter , Facebook or LinkedIn .

Statements about PositiveID's future expectations in this press release and those made in its interview with SmallCapVoice.com , including the likelihood that Firefly Dx reduces time to results as well as cost per test; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to target the bio-threat detection and rapid medical testing sectors; the Company’s ability to complete development of Firefly Dx; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 12, 2016, and 10-Qs filed on May 16, 2016, November 12, 2015, and August 13, 2015, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Contact for PositiveID Corporation Allison Tomek 561-805-8044 atomek@positiveidcorp.com Contact for SmallCapVoice.com: Stuart T. Smith 512-267-2430 info@smallcapvoice.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capricor's Challenges: FDA Review Delays and Legal Woes

Updated Category News Views 21

Capricor Under the Spotlight: FDA and SEC Concerns Ah, Capricor Therapeutics, Inc. (NASDAQ: CAPR)—a tale of high stakes and even higher expectations now hanging by a very taut thread. Investors are feeling the heat as the U.S. Food and Drug Administration (FDA) presses pause on Capricor's plans, and the courtroom drama unfolds with a securities class action looming over...

Continue Reading
La Rosa Holdings Achieves Record Growth with 188% Revenue Surge

Updated Category News Views 144

La Rosa Holdings Reports Impressive Revenue Growth in 2024 Revenue for Q3 2024 Climbs 188% Year-Over-Year to $19.6 Million Aiming for $100 Million in Annualized Revenue by Year-End La Rosa Holdings Corp. (NASDAQ: LRHC) recently disclosed its financial progress, showcasing remarkable growth in the real estate sector. The company revealed that its total revenue witnessed a...

Continue Reading
Navigating the Intricacies of Micron Technology's Options Market

Updated Category News Views 163

Understanding Micron Technology's Market Landscape Investors have recently adopted a bearish stance towards Micron Technology (NASDAQ: MU), a trend that calls for attention among market participants. The sizable options activities we've noticed could hint at significant changes brewing in the market for this semiconductor giant. These insights stem from a comprehensive...

Continue Reading
Viz.ai Unveils New Data Showcasing Stroke Treatment Innovations

Updated Category News Views 288

Viz.ai is cutting through the noise in stroke treatment with its revolutionary technology. They’ve recently unveiled some pretty remarkable clinical data showcasing how their product, Viz LVO, can significantly alter the game for patients dealing with large vessel occlusions—an ischemic stroke that typically spells trouble. This isn’t just another tech story; it’s...

Continue Reading
Linda A. Smith: A Leader in Finance and Budgeting

Updated Category News Views 170

Linda A. Smith Earned Pinnacle Professional Membership Linda A. Smith has made a remarkable mark in the finance sector, and her recent accolade as a Pinnacle Professional Member is a testament to her expertise and commitment. With more than 23 years of experience in finance and budgeting, she brings an impressive array of knowledge and skills to her role. Distinguished...

Continue Reading